Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT01546844
Other study ID # Care4Life Grant
Secondary ID
Status Enrolling by invitation
Phase N/A
First received February 28, 2012
Last updated September 4, 2012
Start date March 2012
Est. completion date February 2013

Study information

Verified date September 2012
Source HealthInsight
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This purpose of this is study is to evaluate the effectiveness of an interactive mobile health information service, Care4Life, in supporting patient self-management of Type II Diabetes Mellitus.


Description:

This study evaluates the effectiveness of an interactive mobile health information service, Care4Life, in supporting patient self-management through its ability to facilitate patient education, behavior change, and improved adherence with standard care practices. The study population comprises adults who have been diagnosed with Type 2 diabetes mellitus (DM) and a hemoglobin A1c (HbA1c) test above 8% in the past year. All members of the study population are treated at primary care clinics under the auspices of the Utah Beacon Community Program, which aims to improve health through use of health information technology. We will compare outcomes in two groups within this population: patients with DM who enroll in Care4Life (in addition to receiving standard care) to patients with DM who receive standard care from their physician. We will compare these groups both within the clinic and at an aggregated, overall level.

This study relies on the use of information and communications technology (ICT) in supporting patient-empowerment strategies. Features of successful diabetes care programs for improving adherence to standards of care, such as the use of diabetes self-management education, checklists that mirror guidelines, and automated reminders are well suited to delivery using an interactive mobile health platform.

Research Questions

This study will evaluate the efficacy of the Care4Life mHealth program by:

1. Evaluating if a short message service via cell phone texting (SMS) protocol will lead to improvements in clinical, utilization and satisfaction outcomes for patients with DM compared to patient who receive standard care.

2. Evaluating if an SMS protocol can be readily adopted by an adult population in both urban and rural areas with a time-consuming chronic illness.

Targeted outcomes include:

1. Improved measures of diabetes control, demonstrated as HbA1c percentage levels ≤ 8%; improved blood pressure (BP) control, demonstrated as BP ≤ 140/90 millimeters mercury (mm Hg); and lower body mass index (BMI) among users of the SMS-based tool.

2. Improved knowledge of self-care and disease management practices among adult patients with diabetes treated in Beacon clinics in the Salt Lake Metropolitan Statistical Area (Salt Lake, Tooele, and Summit counties).

3. Dissemination of results and proof of concept with the broader healthcare community in Utah.

The mobile centric diabetes support service at the center of our study is Voxiva's Care4Life platform, which is an interactive mobile application designed to educate participants, encourage behavior change and promote adherence to their prescribed DM treatment protocol. It includes a series of SMS-based tools that have been developed in collaboration with the Instituto Carso de la Salud, located in Mexico. The service sends content relevant to the target participants and their standard treatment protocol. Care4Life delivers an individually tailored diabetes education and management plan based on data that are collected from patients at enrollment and added to the participant's personal health profile.

The SMS protocol draws on the experience of a number of interventions that have been independently studied and shown to improve health outcomes. Care4Life functionality consists of the following components: (1) a diabetes diary that can be used to develop a history of glucose levels and trigger alerts and feedback based on the participant's results; (2) health education with content tailored to the participant's health profile; (3) medication adherence reminders and monitoring; (4) medical appointment reminders; (5) a database that allows a participant to record and monitor her/his weight, BMI, blood pressure and laboratory results; and (6) a health portal that allows a participant to review his/her data, obtain advice and guidance based on the information entered, and manage his/her preferences.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 500
Est. completion date February 2013
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Laboratory test for HbA1c = 8% within the past year

- Clinical diagnosis of DM

- Age > 18 years old

- Patient in a Beacon clinic

- Cell phone ownership or willingness to acquire a cell phone capable of receiving and sending SMS messages

- Women who are not pregnant

Exclusion Criteria:

- Failure to meet inclusion criteria

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Intervention

Other:
Participation in Care4Life
Text message service to aid patients with self-management of type II Diabetes Mellitus. Includes online access to patient data and management of health goals.

Locations

Country Name City State
United States Coalville Health Center Coalville Utah
United States Pioneer Comprehensive Medical Draper Utah
United States Holladay Family Practice Holladay Utah
United States Olympus Clinic Holladay Utah
United States Exodus Healthcare - Main Office - Magna Magna Utah
United States Community Health Centers Inc. - 72nd Street Clinic Midvale Utah
United States Park City Healthcare, Inc. Park City Utah
United States Granger Medical-Riverton Riverton Utah
United States Riverton Family Health Center Riverton Utah
United States Alpine Internal Medicine Salt Lake City Utah
United States Central City Community Health Center Health First Family Medicine Salt Lake City Utah
United States Evolutionary Healthcare, Llc Salt Lake City Utah
United States Health Clinic Of Utah - SLC Salt Lake City Utah
United States HealthInsight Salt Lake City Utah
United States Jordan Ridge Family Medicine Salt Lake City Utah
United States Stephen D. Ratcliffe Community Health Center Salt Lake City Utah
United States Utah Healthcare Institute - St. Mark's Family Medicine Salt Lake City Utah
United States Utah Physicians Care Centers - St Mark's Internal Medicine Salt Lake City Utah
United States Wasatch Homeless Health Care - 4th Street Clinic Salt Lake City Utah
United States Wasatch Internal Medicine Salt Lake City Utah
United States Barbara E. Rizzardi, M.D. Sandy Utah
United States Copperview Medical Center, Llc South Jordan Utah
United States Community Health Centers Inc. - Oquirrh View Taylorsville Utah
United States Advanced Practice Medical Clinic Tooele Utah
United States Valley Family Medicine Tooele Utah
United States Granger Medical - Jordan Medical Arts West Jordan Utah
United States Jordan Meadows Medical Center West Jordan Utah
United States Granger Medical Clinic Inc. - Main Office West Valley City Utah
United States Kathryn Allen, MD West Valley City Utah
United States West Valley Family And Preventive Medicine West Valley City Utah

Sponsors (3)

Lead Sponsor Collaborator
HealthInsight Center for Technology and Aging, Voxiva

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Hemoglobin A1c - In control, over time. Hemoglobin A1c - In control as assessed by laboratory results of blood draw taken from patient's clinic. In control means a result of <9%. 3, 6, 9, and 12 months No
Secondary Change in Blood Pressure Control over time Improved blood pressure (BP) control as demonstrated as BP = 140/90 millimeters mercury (mm Hg) 3, 6, 9, 12 months No
Secondary Change in BMI over time Lower body mass index (BMI) among users of the SMS-based tool. 3, 6, 9, 12 months No
Secondary Disease Management Improved knowledge of self-care and disease management practices among adult patients with diabetes treated in Beacon clinics in the Salt Lake Metropolitan Statistical Area (Salt Lake, Tooele, and Summit counties). 12 months No
See also
  Status Clinical Trial Phase
Completed NCT01952535 - A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers Phase 1
Completed NCT01196728 - Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Single Doses of CM3.1-AC100 in Patients With Type 2 Diabetes Phase 1
Terminated NCT00997152 - Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients Phase 2
Completed NCT02592421 - SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2 Phase 3
Completed NCT05544214 - Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects Phase 1
Completed NCT01969084 - The Effect of Linagliptin on Mitochondrial and Endothelial Function Phase 4
Terminated NCT01644201 - A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics Phase 3
Completed NCT00995787 - Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and Sulfonylurea Phase 1
Completed NCT01020123 - Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients Phase 2
Completed NCT01505426 - A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients Phase 3
Completed NCT01262586 - Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device. Phase 3
Completed NCT00561171 - Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria Phase 2
Active, not recruiting NCT03912363 - Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids N/A
Completed NCT01868646 - Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus Phase 4
Active, not recruiting NCT06386328 - A Clinical Trial to Evaluate the Food Effect of CKD-378 Phase 1
Terminated NCT02749435 - A Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus N/A
Completed NCT00894868 - Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure Phase 4
Recruiting NCT01165190 - Effect of Pioglitazone on Mitochondrial Function in Muscle and Adipose Tissue in Humans N/A
Completed NCT01255085 - Yellow Pea Protein and Fibre and Short Term Food Intake N/A
Completed NCT02156349 - A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients. N/A